Company Filing History:
4 out of 30 
1 out of 193 
1 out of 2,890 
Years Active: 2017-2021
Title: Innovations and Contributions of Susanne M Steggerda in Biotechnology
Introduction: Susanne M Steggerda, located in San Francisco, CA, is a notable inventor known for her significant contributions to the field of biochemistry and biotechnology. With a total of five patents to her name, she has focused her research on developing therapeutic strategies targeting key mechanisms in cancer treatment.
Latest Patents: Among her latest patents, one notable invention discusses "Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)". This patent describes mutations that confer resistance to BTK inhibitors, as well as modified BTK polypeptides that exhibit decreased inhibition to these inhibitors. The patent also outlines diagnostic methods for detecting the modified polypeptides and their applications, including compositions and kits for using these modified polypeptides. Another important patent relates to "Compositions and methods for inhibiting arginase activity", focused on treating cancer through a combination of an arginase inhibitor and a chemotherapeutic agent, which also includes methods for assessing the efficacy of cancer treatment.
Career Highlights: Susanne has had a successful career with significant experience at prominent biotechnology companies such as Calithera Biosciences, Inc. and Pharmacyclics, Inc. Her work has led to innovative advancements that contribute to the understanding and treatment of complex diseases.
Collaborations: Throughout her career, Susanne M Steggerda has collaborated with talented professionals including Matthew I Gross and Weiqun Li. These partnerships have enhanced her research endeavors and facilitated innovative solutions in biotechnology.
Conclusion: Susanne M Steggerda stands out as a remarkable inventor whose work has greatly impacted the biotechnology field. With a focus on innovative methods for cancer treatment, her patents reflect a commitment to advancing medical science and improving therapeutic outcomes for patients.